Patients' Expectations About the Survival Benefits of Cancer Drugs Approved Based on Progression-Free Survival (NCT07731425)
Patients' Expectations About the Survival Benefits of Cancer Drugs Approved Based on Progression-Free Survival: a Randomized Controlled Trial
🩺 Plain-English Summary (8th-Grade Level)
This study of current or former cancer patients will evaluate whether communicating data on overall survival data in addition to information on progression-free improves the accuracy of cancer patients' expectations about the survival benefits of new cancer drugs
Who can join: Review the eligibility criteria below.
Location: Harvard Medical School and Harvard Pilgrim Health Care Institute — Boston, Massachusetts
Age range: 18 Years
🧪 Interventions in This Study
- FDA explanation for progression-free survival (control) (OTHER)
- FDA explanation for progression-free survival with overall survival data (OTHER)
- NCI explanation for progression-free survival (OTHER)
- NCI explanation for progression-free survival with overall survival data (OTHER)
- Plain-language explanation of progression-free survival (OTHER)
- Plain-language explanation of progression-free survival with overall survival data (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Harvard Medical School and Harvard Pilgrim Health Care Institute — Boston, Massachusetts
📞 Contact the Study Coordinator
Phone: 020 7955 7975
Email: avi_cherla@hphci.harvard.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cancer
- Ovarian Tissue Cryopreservation in Children — Rochester, Minnesota
- A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study — Aurora, Colorado
- Ex Onc SLED: A Study Utilizing A Weighted Sled for Horizontal Resistance Training — Pittsburgh, Pennsylvania
- An Internet-based Program to Help Cancer Survivors Manage Pain — Fort Smith, Arkansas
- Identification of Patients With Age-Related Clonal Hematopoiesis (ARCH) Among Cancer Survivors — Toronto, Ontario
- Researching the Effect of Aerobic Exercise on Cancer — Los Angeles, California
Explore by condition: All Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.